Prevention of invasive fungal infections (IFIs) in ortho-topic liver transplant (OLT) recipients utilizing post-operative systemic antifungal prophylaxis, typically with fluconazole, is justified among those at high risk for IFI. Use of postoperative antifungal prophy-laxis for low-risk OLT recipients is widely practiced but not universally accepted nor supported by data. We conducted a prospective observational study among 200 OLT recipients who were at low risk for IFI and did not receive postoperative antifungal prophylaxis. Pa-tients were considered low risk if they had ≤1 of the following conditions: choledochojejunostomy anasto-mosis; retransplantation; intra-operative administra-tion of ≥units of 40 blood products or return to the op...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
Invasive fungal infections (IFIs) are one of the most important infectious complications after liver...
Antifungal prophylaxis for liver transplant recipients (LTRs) is common among patients considered at...
SummaryInvasive fungal infections (IFIs) in immunocompromised patients, particularly liver transplan...
Although the overall incidence of fungal infections in liver transplant recipients has declined, the...
Background. Whether routine antifungal prophylaxis decreases posttransplantation fungal infections i...
Background. Invasive fungal infection (IFI) following liver transplant is associated with significan...
Invasive fungal infections (IFIs) cause significant morbidity and mortality in liver transplant reci...
Background: Targeted antifungal prophylaxis against Candida species or against Candida species and A...
Background: Targeted antifungal prophylaxis against Candida species or against Candida species and A...
Invasive fungal infections (IFIs) are one of the most feared complications associated with liver tra...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
none13noBackground: Targeted antifungal prophylaxis against Candida species or against Candida speci...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
Invasive fungal infections (IFIs) are one of the most important infectious complications after liver...
Antifungal prophylaxis for liver transplant recipients (LTRs) is common among patients considered at...
SummaryInvasive fungal infections (IFIs) in immunocompromised patients, particularly liver transplan...
Although the overall incidence of fungal infections in liver transplant recipients has declined, the...
Background. Whether routine antifungal prophylaxis decreases posttransplantation fungal infections i...
Background. Invasive fungal infection (IFI) following liver transplant is associated with significan...
Invasive fungal infections (IFIs) cause significant morbidity and mortality in liver transplant reci...
Background: Targeted antifungal prophylaxis against Candida species or against Candida species and A...
Background: Targeted antifungal prophylaxis against Candida species or against Candida species and A...
Invasive fungal infections (IFIs) are one of the most feared complications associated with liver tra...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
none13noBackground: Targeted antifungal prophylaxis against Candida species or against Candida speci...
Objective: To investigate the rate of and the risk factors for breakthrough-IFI (b-IFI) after orthot...
Invasive fungal infections (IFIs) are one of the most important infectious complications after liver...
Antifungal prophylaxis for liver transplant recipients (LTRs) is common among patients considered at...